Loading company details...
Latest Form 4 (Nov 13, 2026): Markus Puhlmann (Chief Medical Officer): Purchase of 6,000 shares, $5.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 13, 2026 | Markus Puhlmann, Chief Medical Officer | Purchase | 6,000 | $5.0K |
| Nov 12, 2026 | Johan M. Spoor, Chief Executive Officer | Purchase | 47,000 | $37.9K |
| Sep 8, 2026 | Lantheus Alpha Therapy, LLC | Sale | 80,783 | $250.9K |
| Sep 4, 2026 | Lantheus Alpha Therapy, LLC | Sale | 42,129 | $131.2K |
| Sep 4, 2026 | Lantheus Alpha Therapy, LLC | Sale | 78,145 | $245.6K |
| Sep 3, 2026 | Lantheus Holdings, Inc. | Sale | 35,769 | $111.6K |
| Sep 2, 2026 | Lantheus Holdings, Inc. | Sale | 78,145 | $245.6K |
| Mar 4, 2026 | Maria E. Martinez | Grant/Award | 50,000 | n/a |
| Mar 4, 2026 | Frank Morich | Grant/Award | 50,000 | n/a |
| Mar 4, 2026 | Robert F. Williamson III | Grant/Award | 50,000 | n/a |